Wound Dressings Market Overview and Introduction

Wound Dressings Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030. The global Wound Dressings market is estimated to be over US$ 10.0 Bn in 2017. It is anticipated to grow at a CAGR of 4.1% from 2019 to 2030.

The wound recovery or healing process is a complex and dynamic procedure, which requires appropriate environment to promote faster healing. Advancement in technology has led to the development of different types of wound care products, which specifically targets diverse aspects of the process of wound healing. The wound dressings products prevents contamination of wound from external elements, including bacteria and other microbes, thereby preventing infections and ensuring faster recovery period.

The global wound dressings market is driven by technological advancements in the wound treatment arena coupled with increasing geriatric population. Increasing patient awareness and health care expenditure, rising prevalence of chronic wounds, namely diabetes and rising need for treatment of complex wounds are major factors driving the market. However, high cost related to wound care products is likely to restrain the market to a certain extent.

Wound Dressings Market by Type

On the basis of type, the market is segmented into advanced and traditional. The advanced wound dressings segment can be further segmented into hydrocolloids, film dressings, collagen dressings, foam dressings, alginates, hydrogels dressings, and other advanced wound dressings. Whereas, traditional wound dressings segment can be classified into anti-infective dressings, surgical tapes, dry dressings, and other traditional wound dressings. The segment of advanced wound dressings is anticipated to account for the highest market share in 2018, owing to faster healing time and minimal chances of infections.

Wound Dressings Market by Applications

On the basis of application, the market is segmented into ulcers, surgical wounds, traumatic wounds, burns, and other applications. The ulcers segment is estimated to account for the largest share of the global market. The large share of this segment can be attributed to the rising incidence of diabetic foot ulcers & pressure ulcers and increasing prevalence of post-operative surgical wounds.

Based on wound type, the market is segmented into surgical wounds, ulcers, traumatic wounds, burns, and other wounds. The surgical wounds segment is estimated to account for the largest share of the global market. The large share of this segment can be attributed to the rising incidence of diabetic foot ulcers & pressure ulcers and increasing prevalence of post-operative surgical wounds. On the basis of the end user, the market is segmented into hospitals and clinics, home care settings, and other end users. The hospitals and clinics segment is estimated to account for the largest share of this market. Increasing wounds related to diabetic foot, and venous leg ulcer and the rising incidence of hospital-acquired pressure ulcers are some of the factors driving the growth of the end-user segment.

Wound Dressings Market by Regions

The global Wound Dressings market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of advance wound care, followed by Europe and Asia Pacific. North America will continue to dominate the global market in the forecast period owing to factors such as growing need of wound care products and highly developed healthcare system. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, India, and Japan. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the market in this region. The high cost of wound dressings products and chronic wound treatment may restrain market growth to a certain extent.

Wound Dressings Market Prominent Players

The prominent players in the global wound dressings market are Acelity L.P., Inc., Integra Lifesciences Holdings Corp., Convatec, Inc., Organogenesis Inc., 3M Company, Smith and Nephew PLC, Mölnlycke Health Care, Coloplast Corp., Medline Industries, Inc., and Covidien PLC